C2i's Yunshi Liao awarded at the Health Research Symposium 2024
C2i at the I&T Awards 2024 Reception
C2i and ANU Join Forces in Vaccine Development and Biotechnology
C2i’s Revolutionary Breakthroughs in Respiratory Diseases Garner Top Honours at the 49th International Exhibition of Inventions Geneva
C2i & Hitachi To Collaborate On Automation Of Organoid Cell Culture & Mass Production of Exosomes
HKUMed, Cambridge and International Vaccine Institute unite to launch HKJC Global Health Institute
1,000 Participants: A New Milestone Reached For HHGP-Hong Kong
Think Business, Think Hong Kong
Congratulations to Leo Poon, New Chair Professor of Public Health Virology!
[Press Release] SARS-CoV-2: How The History Of Human Populations Influences Their Immune Response
C2i & HKUMed Investigate Vaccine Effectiveness Against Omicron Infection
The Pasteur Network LP200 Prize awarded to Leo Poon
RTHK: C2i Investigating Individual Immune Responses
[Exhibition] From Louis to Pasteur, 1822-1895 in Science Park
[Press Release] C2i & HKU lead the way to benchmark immune health
[Podcast] How does the Global South handle COVID-19?
Hong Kong SAR Government to Launch the InnoHK Initiative
SARS-CoV-2 Omicron Variant BA.2 Neutralisation in Sera of Vaccinated or Infected People
Omicron variant can multiply 70 times faster than other strains in lower respiratory tracts of hosts
Malik Peiris finds Omicron significantly reduces virus neutralisation ability of BioNTech vaccine